Transglutaminase 2 Binds to the CD44v6 Cytoplasmic Domain to Stimulate CD44v6/ERK1/2 Signaling and Maintain an Aggressive Cancer Phenotype.
Article in Molecular Cancer Research (May 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Molecular Cancer Research (May 2023)
Article in Biomedicine & Pharmacotherapy (April 2023)
Article in Molecular Carcinogenesis (December 2022)